Clinical trial on Ebola in Guinea

03/27/2017

Clinical Trial, Guinea, Research & innovation

ALIMA conducted a clinical trial on Ebola in Guinea. Watch the video.

Related news

First-ever global alliance of researchers, health workers, and humanitarians join forces to fight the deadly Lassa fever virus

02/27/2024

Fighting against the silent death of women in childbirth in Guinea

09/18/2023

staff ALIMA devant la CUBE pour traiter EBOLA

ALIMA participates in Ebola vaccine trial with promising results

12/22/2022

Subscribe to our monthly newsletter

By subscribing to the ALIMA newsletter, you agree to receive information from us. You can unsubscribe at any time using the unsubscribe links. To understand the use of your data collected by this form, please consult our privacy policy.

Contact Legal notice Press Cookies

For the United States: 100% of your donation will be tax-deductible. ALIMA USA, Inc., is recognized as tax-exempt under section 501(c)(3) of the Internal Revenue Code. EIN: 26-0397519.
For France: Association Law 1901 – Registration and SIREN number : 831 620 398

Under the French tax system, you will benefit from an income tax reduction of 75% of the amount of your donations up to a maximum of 1 000 euros. Beyond that amount, donations are 66% tax deductible up to an equivalent of 20% of your taxable income.